CorMedix Inc at JPMorgan Healthcare Conference Transcript
Hi, all, and welcome to the session. My name is Arvin and I'm an associate at JPMorgan. I'm excited today to introduce CorMedix with us today. We have Joe Todisco, Chairman and CEO.
And just a reminder on for now, we'll have a 20-minute presentation followed by 20 minutes of Q&A. So please hold all your questions till the end. Thank you.
Thank you, [Arvin]. I know it's late in the day, so I appreciate such a packed room, for this time of day, and I know it's been long, so I'll TRY and keep it succinct, but I am Joe Tedisco. I'm the Chairman and CEO of Cormetics, and welcome to Cormetics 2026 JPMorgan presentation.
A quick look at our forward-looking statements, which you can find in more detail in our SEC filings.
And I'll start by talking a little bit about who is Cormetics Therapeutics. So Cormix Therapeutics is a diversified specialty pharmaceutical company with a portfolio of commercial and pipeline drugs predominantly focused on
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
